Bambusa Therapeutics, Inc. (BBTX) stock
BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.00+0.00 (0.00%)
Close on Nov 3, 2026Market cap –P/E –Yield –
Earnings
No earnings reports from Bambusa Therapeutics yet
Quarterly results appear here once Bambusa Therapeutics files an earnings release with the SEC (Form 8-K, Item 2.02, or Form 6-K).
See a number that looks wrong?